Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

COSCIENS Biopharma Inc T.AEZ


Primary Symbol: T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Bullboard Posts
Comment by slagheapon Aug 29, 2015 1:50am
147 Views
Post# 24061770

RE:RE:RE:RE:RE:what a disaster

RE:RE:RE:RE:RE:what a disasterThat formula may be correct as it pertains to how many shares will be issued to the B warrant holders relative to the share price...but...there will also be a second formula the B warrant holders are using to maximize their returns and that may not be to issue as many shares as possible while driving down the share price. I mean this; Which is a better return; 1b shares issued and a share price of 3 cents or 700m shares issued at 8 cents or 500m shares issued at 10 cents. Because we don`t know their formula we cannot predict a bottom.

One important number to keep in mind is the NAZ minimum market cap of $35m to maintain their listing which translates as 1b shares at 3.5 cents or 500m shares at 7 cents or 700m shares at 5 cents. It would be nice and easy to have the share price drop to 3 cents and then we could really load up because the shorting has skewered the market cap considering that 1b shares and a cash position of $60m equals 16 cents per share. Share consolidation in December to meet another NAZ listing requirement of minimum share price of 1 dollar.
Bullboard Posts